Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exozymes (EXOZ) Change in Accured Expenses (2023 - 2024)

Exozymes (EXOZ) has disclosed Change in Accured Expenses for 2 consecutive years, with $300247.0 as the latest value for Q4 2024.

  • Quarterly Change in Accured Expenses fell 24.82% to $300247.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $221340.0 through Dec 2024, changed N/A year-over-year, with the annual reading at $311085.0 for FY2025, 40.55% up from the prior year.
  • Change in Accured Expenses for Q4 2024 was $300247.0 at Exozymes, up from $273184.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $399357.0 in Q4 2023, with the low at -$405857.0 in Q2 2024.